2014
DOI: 10.1016/j.freeradbiomed.2014.10.013
|View full text |Cite
|
Sign up to set email alerts
|

Cellular Senescence and Brain Aging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
36
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(36 citation statements)
references
References 0 publications
0
36
0
Order By: Relevance
“…Our findings, taken together with the results of earlier studies (reviewed in Warrington et al (2013)), point to potential benefits of interventions that rescue glio-vascular coupling mechanisms and promote microvascular health for prevention of cognitive decline both in WBI-treated patients and the elderly. There is increasing realization that DNA damage-induced cellular senescence programs play a critical role in brain aging process (reviewed in Chinta et al (2014)), thus we propose that the present clinically relevant model of fractionated WBI should be considered to study fundamental mechanisms of brain and cognitive aging as well.…”
Section: Discussionmentioning
confidence: 99%
“…Our findings, taken together with the results of earlier studies (reviewed in Warrington et al (2013)), point to potential benefits of interventions that rescue glio-vascular coupling mechanisms and promote microvascular health for prevention of cognitive decline both in WBI-treated patients and the elderly. There is increasing realization that DNA damage-induced cellular senescence programs play a critical role in brain aging process (reviewed in Chinta et al (2014)), thus we propose that the present clinically relevant model of fractionated WBI should be considered to study fundamental mechanisms of brain and cognitive aging as well.…”
Section: Discussionmentioning
confidence: 99%
“…Originally derived from the study of cancer cells, cellular senescence implied a loss of the ability to divide (Campisi ). However, more recently this has come to imply an age‐related change in the secretory profile, as in the senescence‐associated secretory phenotype (SASP) (Coppe et al ; Chinta et al ). Dystrophic on the other hand is a term derived from a morphological change as observed from the study of brain sections (Streit et al ).…”
mentioning
confidence: 99%
“…Increasing evidences are showing that senescent cells are detectable in mammalian brains along with the aging process, and may also be implicated in NDDs. (8,98,99) As an indicator of cellular senescence telomere length has been proposed as a biomarker of human aging. (100) In general, telomere length reflects the balance between additions and losses of TTAGGG repeats (101) and it can be accelerated by many factors, such as oxidative stress, replication stress, and inflammation (102).…”
Section: Dna Damage and Nddmentioning
confidence: 99%
“…The disappointing outcomes of dozens of phase III clinical trials of treatments for AD and PD indicate a need for fresh approaches to identify novel targets that drive processes that cause agerelated neuropathology. (8) Currently available treatments (social supports, mobility aides, and "Band-Aid" treatments for end-stage, downstream symptoms) are not directed at the root causes of age-related dysfunction. Treating chronic diseases one at a time does not suffice.…”
Section: Introductionmentioning
confidence: 99%